Nasovac, a vaccine for swine flu has been launched by a Pune-based firm Serum Institute of India Ltd on Wednesday (July 14). Nasovac is priced at Rs 160 per dose and can be used only for adults and children above three years.
SERUM INSTITUTE of India Ltd, a Pune-based firm launched a vaccine- ‘Nasovac’ for swine flu on Wednesday (July 14).
Executive director (Operations) Adar C Poonawalla, Serum Institute of India Ltd told reporters, “Nasovac is a indigenously developed intra-nasal vaccine for swine flu, a pandemic that has claimed over 1,000 lives in the country since its outbreak in May last year.”
Poonawalla stated that the firm is in the process of developing an anti-swine flu vaccine for children below three years that is likely expected to hit the market in the next two to three months.
Nasovac is priced at Rs 160 per dose and can be used only for adults and children above three years. However, the firm made it clear that this vaccine should not be given to pregnant and lactating women.
"Our recommendation is that it (Nasovac) should not be administered to pregnant and lactating women, besides children below three years," Poonawalla said.
"But the medical fraternity says this decision should be left to them. They think that if the women are in a high-risk area, they should be vaccinated. So, we have no objection, but it is better that if these vaccines are not given to them," Poonawalla pointed out.
The firm in order to increase from 45 million doses to around 135 million doses, has envisaged an investment of over Rs 100 crore.
"We have spent about Rs 50 crore on the pilot plant," Poonawalla said, adding the firm plans to spend more to triple the capacity in one to two years.
The company had donated vaccines worth Rs 10 crore to various hospitals, non-government organisations and the underprivileged, executive director Poonawalla claimed.